STIMUFEND 6 mg/.6mL
pegflilgrastim-fpgk · INJECTION, SOLUTION · Fresenius Kabi USA, LLC
STIMUFEND is a injection, solution containing pegflilgrastim-fpgk at 6 mg/.6mL, taken subcutaneous. Manufactured by Fresenius Kabi USA, LLC.
Key Facts
- Brand Name
- STIMUFEND
- Generic Name
- pegflilgrastim-fpgk
- NDC Code (Product)
65219-371- Manufacturer
- Fresenius Kabi USA, LLC
- Strength
- 6 mg/.6mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761173
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 10/06/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is STIMUFEND used for?
STIMUFEND contains pegflilgrastim-fpgk. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is STIMUFEND a controlled substance?
STIMUFEND is not classified as a controlled substance by the DEA.
What is the generic name for STIMUFEND?
The generic name for STIMUFEND is pegflilgrastim-fpgk. There are no other listed brand versions of pegflilgrastim-fpgk.
What is the NDC code for STIMUFEND 6 mg/.6mL?
The NDC (National Drug Code) for STIMUFEND 6 mg/.6mL is 65219-371, listed by Fresenius Kabi USA, LLC.
Other STIMUFEND Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)